Table 5.

Odds Ratios for Having High-Risk CRP Level

ω-6:ω-3 Ratio Tertile and Supplement Use	Odds Ratio	95% CI
Model 1*
Lowest, nonusers v lowest, users	3.1	1.3 to 7.4
Middle, users v lowest, users	1.8	0.6 to 5.6
Middle, nonusers v lowest, users	3.6	1.5 to 8.7
Highest, users v lowest, users	2.4	0.6 to 5.6
Highest, nonusers v lowest, users	4.6†	1.9 to 11.0
Model 2‡
Lowest, nonusers v lowest, users	2.7	1.1 to 6.5
Middle, users v lowest, users	1.8	0.5 to 5.6
Middle, nonusers v lowest, users	2.9	1.2 to 7.1
Highest, users v lowest, users	2.2	0.6 to 9.0
Highest, nonusers v lowest, users	3.8§	1.6 to 9.3
Model 3‖
Lowest, nonusers v lowest, users	3.2	1.2 to 8.4
Middle, users v lowest, users	1.8	0.5 to 6.5
Middle, nonusers v lowest, users	3.3	1.3 to 8.6
Highest, users v lowest, users	2.6	0.6 to 11.4
Highest, nonusers v lowest, users	4.5§	1.7 to 11.5

Abbreviation: CRP, C-reactive protein.

^*Model 1 adjusts for age, race/study site, tamoxifen use, and menopausal status.

^†P < .01 comparing odds ratios for being fatigued across subgroups determined by ω-6:ω-3 ratio tertile and supplement use.

^‡Model 2 adjusts for model 1 plus antidepressant/anxiolytic use and number of comorbidities.

^§P < .05 comparing odds ratios for being fatigued across subgroups determined by ω-6:ω-3 ratio tertile and supplement use.

^‖Model 3 adjusts for model 2 plus body mass index.